Xiao-Shuang Zheng
Overview
Explore the profile of Xiao-Shuang Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
13137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang R, Luo Y, Lin H, Zheng X, Zeng W, Liu M, et al.
iScience
. 2025 Feb;
28(2):111837.
PMID: 39981511
Comorbidities, such as obesity, increase the risk of severe COVID-19. However, the mechanisms underlying severe illnesses in individuals with obesity are poorly understood. Here, we used gene-edited leptin knock out...
2.
Zheng X, Wang Q, Xie T, Si H, Zhang W, Zhu Y, et al.
Emerg Microbes Infect
. 2023 Jun;
12(2):2225932.
PMID: 37334745
Zoonotic coronaviruses (CoVs) caused major human outbreaks in the last two decades. One of the biggest challenges during future CoV disease is ensuring rapid detection and diagnosis at the early...
3.
Zheng X, Wang Q, Min J, Shen X, Li Q, Zhao Q, et al.
J Virol
. 2022 Apr;
96(9):e0003822.
PMID: 35420442
Due to the limitation of human studies with respect to individual difference or the accessibility of fresh tissue samples, how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection results in...
4.
Shen X, Geng R, Li Q, Chen Y, Li S, Wang Q, et al.
Signal Transduct Target Ther
. 2022 Mar;
7(1):83.
PMID: 35277473
SARS-CoV-2 induced marked lymphopenia in severe patients with COVID-19. However, whether lymphocytes are targets of viral infection is yet to be determined, although SARS-CoV-2 RNA or antigen has been identified...
5.
Shen X, Li Q, Li H, Wang X, Wang Q, Zheng X, et al.
Viruses
. 2021 Dec;
13(12).
PMID: 34960752
Patients with COVID-19 generally raise antibodies against SARS-CoV-2 following infection, and the antibody level is positively correlated to the severity of disease. Whether the viral antibodies exacerbate COVID-19 through antibody-dependent...
6.
Luo Y, Chen Y, Geng R, Li B, Chen J, Zhao K, et al.
Virol Sin
. 2020 Nov;
36(3):559-563.
PMID: 33201410
No abstract available.
7.
Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W, et al.
Nature
. 2020 Nov;
588(7836):E6.
PMID: 33199918
No abstract available.
8.
Li Q, Zheng X, Shen X, Si H, Wang X, Wang Q, et al.
Emerg Microbes Infect
. 2020 Nov;
9(1):2571-2577.
PMID: 33196399
Following acute infection, individuals COVID-19 may still shed SARS-CoV-2 RNA. However, limited information is available regarding the active shedding period or whether infectious virus is also shed. Here, we monitored...
9.
Zhang W, Du R, Li B, Zheng X, Yang X, Hu B, et al.
Emerg Microbes Infect
. 2020 Feb;
9(1):386-389.
PMID: 32065057
In December 2019, a novel coronavirus (2019-nCoV) caused an outbreak in Wuhan, China, and soon spread to other parts of the world. It was believed that 2019-nCoV was transmitted through...
10.
Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W, et al.
Nature
. 2020 Feb;
579(7798):270-273.
PMID: 32015507
Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large number of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats. Previous studies...